124 related articles for article (PubMed ID: 16112951)
1. Is mammographic density, as currently measured, a robust surrogate marker for breast cancer?
Yaffe M; Hendrix S; Pike M; Santen R; Eden J; Genazzani A
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():17-21. PubMed ID: 16112951
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.
Santen R
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():12-6. PubMed ID: 16112950
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone therapy and mammographic breast density.
Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
5. [Menopausal hormonal therapies: impact on mammographic breast density].
Boutet G; Boisserie-Lacroix M; Trillaud H
J Radiol; 2004 Oct; 85(10 Pt 1):1673-86. PubMed ID: 15669560
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone replacement therapy on mammographic findings.
Bülbül NH; Ozden S; Dayicioglu V
Arch Gynecol Obstet; 2003 Apr; 268(1):5-8. PubMed ID: 12673467
[TBL] [Abstract][Full Text] [Related]
7. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
Jamin C; Bourg F; Legeai J; Senoussi S
Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy, mammographic density, and breast cancer risk.
Martin LJ; Minkin S; Boyd NF
Maturitas; 2009 Sep; 64(1):20-6. PubMed ID: 19709825
[TBL] [Abstract][Full Text] [Related]
10. [Effects of hormonal replacement therapy on breast density in postmenopausal women].
Bisanti T; Cavalieri AP; Capri O; Galoppi P; De Felice C; Porfiri LM; Perrone G
Minerva Ginecol; 2004 Apr; 56(2):125-30. PubMed ID: 15258540
[TBL] [Abstract][Full Text] [Related]
11. [Hormones and mammographic breast density].
Boisserie-Lacroix M; Lebiez-Michel N; Cavagni P; Bentolila J; Laumonier H; Bouzgarrou M; Trillaud H
J Radiol; 2008 Sep; 89(9 Pt 2):1196-203. PubMed ID: 18772804
[TBL] [Abstract][Full Text] [Related]
12. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy.
Nahas-Neto J; Luca LA; Griva BL; Morceli J; Nahas EA; Moriguchi SM; Uemura G; Traiman P
Maturitas; 2006 Jan; 53(1):97-106. PubMed ID: 15941630
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
[TBL] [Abstract][Full Text] [Related]
15. Mammographic breast density changes after 1 year of tibolone use.
Kutlu T; Fiçicioğlu C; Başaran T; Başaran E; Topaloğlu T
Maturitas; 2004 Jun; 48(2):133-6. PubMed ID: 15172087
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and mammographic density.
Kilicdag EB; Bagis T; Pourbagher A; Tarim E
Int J Gynaecol Obstet; 2004 Jul; 86(1):56-8. PubMed ID: 15207680
[No Abstract] [Full Text] [Related]
17. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
Lundström E; Hirschberg AL; Söderqvist G
Maturitas; 2011 Dec; 70(4):361-4. PubMed ID: 21958943
[TBL] [Abstract][Full Text] [Related]
18. [Breast density: a major parameter to follow during hormone replacement therapy].
Gairard B; Guldenfels C; Haehnel P; Mathelin C
Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
[TBL] [Abstract][Full Text] [Related]
19. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity.
Harvey JA; Pinkerton JV; Herman CR
J Natl Cancer Inst; 1997 Nov; 89(21):1623-5. PubMed ID: 9362162
[No Abstract] [Full Text] [Related]
20. Breast density as a clinical entity: is it a marker for breast cancer?
Nachtigall LE
Menopause; 2007; 14(3 Pt 1):345-6. PubMed ID: 17413840
[No Abstract] [Full Text] [Related]
[Next] [New Search]
